Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 794 shares at $57.54 ($46K) on 2025-02-11, disclosed to the SEC on 2025-02-11.
Scheduled sale ($46k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.51 | 791 | $45K | 99.6% |
| 2 | $57.54 | 3 | $173 | 0.4% |
| Total | $57.51 avg | 794 | $46K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |